This page shows the details of why an item matched the keywords from your search.
| Item Type | Name |
|
Academic Article
|
A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease.
|
|
Academic Article
|
Incidence of Trypanosoma cruzi infection in triatomines collected at Indio Mountains Research Station.
|
|
Academic Article
|
Purification of Glycosylphosphatidylinositol-Anchored Mucins from Trypanosoma cruzi Trypomastigotes and Synthesis of a-Gal-Containing Neoglycoproteins: Application as Biomarkers for Reliable Diagnosis and Early Assessment of Chemotherapeutic Outcomes of Chagas Disease.
|
|
Academic Article
|
A prophylactic a-Gal-based glycovaccine effectively protects against murine acute Chagas disease.
|
|
Academic Article
|
Trypanosoma cruzi oleate desaturase: molecular characterization and comparative analysis in other trypanosomatids.
|
|
Academic Article
|
2,3-diphenyl-1,4-naphthoquinone: a potential chemotherapeutic agent against Trypanosoma cruzi.
|
|
Concept
|
Chagas Disease
|
|
Academic Article
|
Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease.
|
|
Academic Article
|
Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.
|
|
Academic Article
|
Surveillance of Trypanosoma cruzi infection in Triatomine vectors, feral dogs and cats, and wild animals in and around El Paso county, Texas, and New Mexico.
|
|
Academic Article
|
New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia.
|